Skip to main content
. 2013 Aug 6;3:18. doi: 10.1186/2191-1991-3-18

Table 4.

Probability that palivizumab is cost-effective for different WTP thresholds

Sub-group WTP threshold £20,000 WTP threshold £30,000
CHD
36.76%
51.52%
CLD
45.04%
60.06%
<29 wGA
45.02%
51.22%
29-32 wGA
30.44%
36.78%
33-35 wGA 2.8% 5.4%

Abbreviations: CHD Congenital heart disease, CLD Chronic lung disease, wGA weeks of gestational age, WTP Willingness to pay.